BRIEF: Cloudbreak tumbles in Hong Kong trading debut
Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) opened down 6% in its Hong Kong trading debut on Wednesday, and continued to fall during the morning session to close down 30% at HK$7.04…
BRIEF: Cloudbreak launches $78 million Hong Kong IPO
Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) launched its Hong Kong IPO on Tuesday, aiming to sell 60.58 million shares at HK$10.10 apiece to raise about HK$610 million ($78 million). Share…
BRIEF: Bayzed Health jumps in Hong Kong trading debut
Shares of cancer hospital operator Bayzed Health Group Inc. (2609.HK) jumped in their Hong Kong trading debut on Monday, as the company raised HK$562 million ($72 million) in an IPO that received…
BRIEF: BrainAurora CEO resigns, citing health reasons
BrainAurora Medical Tech Ltd. (6681.HK) announced on Friday that its CEO and chief research officer Wang Xiaoyi resigned, effective Thursday, due to health issues caused by worsening depression. The company…
BRIEF: Green Economy invests $1.48 million in Bayed Health Group IPO
Building maintenance services company Green Economy Development Ltd. (1315.HK) said on Wednesday it will invest HK$11.6 million ($1.48 million) in shares of Bayzed Health Group Inc. (2609.HK) during the biotech…
BRIEF: Hengrui executive to sell nearly 500,000 A-shares
Pharmaceutical company Jiangsu Hengrui Pharmaceuticals Co. Ltd. (1276.HK; 600276.SH) said on Sunday that executive director and senior vice president Sun Jieping will sell up to 476,700 of his A-shares in…
BRIEF: Bayzed Health to raise up to $115 million in Hong Kong IPO
Cancer hospital operator Bayzed Health Group Inc. (2609.HK) launched its Hong Kong IPO on Friday, aiming to raise up to HK$900 million ($115 million). The company said it plans to…